Lose Weight With Tirzepatide
Mounjaro (Tirzepatide) is used in combination with diet and exercise to achieve weight loss if you’re overweight.
It is a once-weekly injection for improving blood sugar in adults.
- Balances blood sugar
- Same active ingredient in Wegovy® and Ozempic®.
- Personalized weight loss plans from meto’s licensed experts
Everything you need to know about Injectable compounded Tirzepatide
What is Mounjaro Tirzepatide
Mounjaro (Tirzepatide) is a synthetic peptide that mimics the action of two incretin hormones involved in blood sugar control which are glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). This dual mimetic action makes it the first drug of its kind to act on both of those receptors.
Mounjaro reduces fasting and postprandial glucose concentrations, food intake, and body weight in patients with type 2 diabetic patients, obesity, or excessive body fat.
Is Tirzepatide effective for weight loss?
Tirzepatide, the active ingredient in Mounjaro, is a quick, safe, and effective way to lose weight.
It has been shown in clinical trials to help individuals lose up to 21% of their initial body weight when combined with a reduced-calorie diet and increased physical activity, when compared to participants who took a placebo
Mounjaro (tirzepatide) has numerous advantages, including weight loss and improved control of diabetes symptoms. Weight loss of 20% or more has been demonstrated in clinical trials after a year of treatment with Mounjaro (tirzepatide).
Mounjaro (tirzepatide) is projected to be even more effective than GLP-1 alone, making it an appealing option for anyone seeking safe and effective weight loss options.
How Does Trizepatide Work?
Mounjaro (Tirzepatide) is a single molecule that stimulates the two natural incretin hormones; insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.
GLP-1s stimulate the pancreas to create insulin after meals, which lowers blood sugar levels. They suppress hunger by binding to receptors in the brain that release chemicals which suppress your appetite by stimulating brain locations that regulate food intake. On the other hand, GIP has been demonstrated to reduce your appetite and raise your energy expenditure, resulting in weight loss. The pairing of GIP and GLP-1 agonist may have a greater favorable effect on blood glucose and body weight.
Mounjaro (Tirzepatide) aids weight loss by decreasing food intake and slowing the rate at which food travels through your digestive tract (a process known as gastric emptying). This may help you feel filled for longer periods of time, allowing you to eat less food.
Mounjaro (tirzepatide) may be an expensive medication, costing over $1000.
Alternative medication
Mounjaro (tirzepatide) is one of the multiple GLP-1 weight-loss classes of drugs. Other GLP-1 drug classes include:
